Individualized alemtuzumab dosing for induction of disease remission prior to HSCT in children with HLH

Achini-Gutzwiller, FR; Vermont, CL; van Montfrans, JM; Moshous, D; Jansen-Hoogendijk, AM; van Ostaijen-ten Dam, MM; Schilham, MW; Moes, DJA; Lankester, AC; Buddingh, EP

BONE MARROW TRANSPLANTATION, 2022; 57 (SUPPL 1): 84

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索